Our Company

ABOUT MANHATTAN SCIENTIFICS

The Company's business model capitalizes on inventions and technology from which profits are created through licensing. MSI is dedicated to earning profit for its 8,600 shareholders by identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market.

We emphasize novel technology in the Nanomedicine space with the potential to be disruptive and the ability to establish sustainable businesses.

We are "patient capital" with experienced business building partners who bring the perspective of merchant bankers, not venture capitalists. Our approach to assist scientists to commercialize their work is by providing a forum within which the commercialization process is fostered through partnerships with existing companies (Fortune/1000 or larger). The entrepreneurial scientists and engineers who join us create personal success and wealth on an accelerated basis by virtue of ownership of publicly traded Manhattan Scientifics shares (OTC BB: MHTX).

HOW TO WE DIFFER FROM VENTURE CAPITALISTS?

MSI distinguishes itself from most venture capital firms in that it uses its own, rather than managed, capital owned by others. Consequently, MSI actions are not constrained by pre set rules and fund-life-time-tables, and we avoid many of sometimes-adversarial aspects of venture capital relationships.

MOTIVATION FOR OUR ENTREPRENEUR SCIENTIST PARTNERS

Because Wall Street tends to establish stock values several years ahead of earnings achievement and fungible measurable success, values tend to be assigned for early stage produce entering the marketplace, or even prior to market entry. Thus, recognition, personal success and wealth may be achieved by our entrepreneurial scientist partners on an accelerated basis, since they become significant shareholders of MSI.

Technologists who are partnered with our company also enjoy the diversity of shared success with their brother technologists at MSI…success at any one of the company’s technologies finds way into the value of our shares and the success is shared by the entrepreneur whose concept or acceptance in the market place has not yet matured.

BRINGING PRODUCT TO THE MARKET

MSI believes that the ideal route to commercial success for a new or emerging technology may best be achieved by “hitching one’s wagon to a star”….joining with one or more major industrial companies who possess the deep pockets necessary to manufacture and market. Such companies allow the new technology to avoid the many pitfalls of the “Do it yourself” approach to start-ups (most of which fail). Our company earns profit through royalty-bearing licenses as part of the technology transfer process.